Product Information
VENLAFAXINE HCL ER 75 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2852 per EA under NDC 70710134909. Its NADAC has been published 181 times since Apr 19, 2023.
FDA first approved this application on Aug 30, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710134909
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215622FDA Approved
8/30/2022
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 75 MG TAB has been published 181 times since Apr 19, 2023, and over the history we have for it it has declined 75.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2852 per EA |
|---|---|
| All-time high | $1.1864 (Aug 16, 2023) |
| All-time low | $0.1937 (Jul 17, 2024) |
| 52-week high | $0.8071 |
| 52-week low | $0.2612 |
| Median price | $0.4710 |
| Average price | $0.5469 |
| Largest weekly change | -60.3% (Aug 23, 2023) |
| Weeks tracked | 181 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Venlafaxine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 75 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 75 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2852 per EA (NDC 70710134909), effective Sep 30, 2026.
How has the price of VENLAFAXINE HCL ER 75 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 75 MG TAB has declined 75.1%. It has been tracked across 181 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 75 MG TAB?
Since Apr 19, 2023, the NADAC for VENLAFAXINE HCL ER 75 MG TAB has ranged from a low of $0.1937 (Jul 17, 2024) to a high of $1.1864 (Aug 16, 2023), with a median of $0.4710 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 75 MG TAB?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL 75 MG TABLET, is $0.0851 per EA — about 70% below VENLAFAXINE HCL ER 75 MG TAB.
Who manufactures VENLAFAXINE HCL ER 75 MG TAB?
VENLAFAXINE HCL ER 75 MG TAB (NDC 70710134909) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.